ArticleJournal of family medicine and primary care2025
Time-to-event analysis of COVID-19 precautionary dose vaccination among healthcare workers in a teaching institute of a metropolitan city in India, using Co-WIN data.
Article in Journal of family medicine and primary care, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Vaccination emerged as a significant and critical intervention for tackling the Covid-19 pandemic. During vaccine introduction in India, healthcare and front-line workers were prioritized to receive the vaccine first. This study aims to analyze the uptake patterns of precautionary doses among HCWs for Covishield and Covaxin vaccines using time-to-event analysis. Design: Retrospective Observational study. Setting: Covid Vaccination center at a teaching institute in Mumbai. Participant: Healthcare Workers (HCWs) who received precautionary doses of Covishield or Covaxin between January 10, 2022, and July 6, 2022, at the Covid vaccination center in a teaching institute in Mumbai. Results: 2,615 HCWs received Covishield and 93 received Covaxin precautionary doses. For Covishield, 86.5% took the precautionary dose within two weeks, with a mean uptake time of 9.1 days. Younger age groups and females showed higher uptake times. For Covaxin, 57% took the precautionary dose within two weeks, with a mean uptake time of 32.98 days. Younger age groups had higher uptake times, while females had lower uptake times for the precautionary dose. Cox regression identified younger age as a significant predictor of delayed uptake for Covishield. Conclusion: HCWs showed good overall acceptance of precautionary doses, with improved uptake compared to initial doses. Females and younger age groups generally had longer uptake times. These findings highlight the need for targeted education and risk communication strategies to ensure timely vaccination among HCWs. The study also highlights the value of having good data stored in vaccination platforms, analyzed, and interpreted for informed decision-making in future health campaigns.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.